The Research and Development team at Viriom focuses on advancing innovative therapeutic and preventative solutions for HIV and hepatitis B virus (HBV). Comprising experts in scientific research and discovery, the team conducts cutting-edge studies, develops new drug candidates, and evaluates their efficacy and safety to drive the company's late-stage development pipeline.
View all